Dr. Mohsan Saeed’s laboratory at Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) is seeking a highly motivated Postdoctoral Associate for a project on the interplay between proteases and antiviral immunity. The candidate will investigate the molecular details of how viral and cellular proteases shape the human antiviral defense mechanisms. The work will employ stem cell-derived models of virus infection and utilize modern molecular techniques, including CRISPR/Cas9, proximity-based protein labeling, proteomics, single-cell RNA sequencing, and high-resolution cell imaging. The strong conceptual and technological foundation of the proposed projects and the presence of compelling preliminary data present a solid platform for several high-quality publications.

The candidate will benefit from:

• The high-tech facilities and an extremely resourceful environment of the NEIDL (https://www.bu.edu/neidl/)
• Saeed lab’s ongoing collaborations with several groups at Harvard Medical School, MIT, Broad Institute, and Boston University School of Medicine
• Saeed lab’s close partnerships with Boston University’s Center for Regenerative Medicine (https://www.bu.edu/dbin/stemcells/) and Center for Network Systems Biology (https://cnsb.bu.edu/home-page/)
• NEIDL’s extraordinary seminar series featuring world-renowned experts in virology, emerging infectious diseases, and immunology
• A large number of outstanding benefit programs offered by the Boston University (www.bu.edu/benefits)
• A highly rich academic environment of the city of Boston.

The ideal candidate should have a recent Ph.D. or equivalent degree in molecular biology, extensive experience with viruses and innate immunity, first-author publications in peer reviewed journals, strong communication and analytical abilities, and enthusiasm for basic science research. The candidates with expertise in the CRISPR/Cas9 technology and/or computational biology will be preferred.

Please send your resume/CV and list of publications to Dr. Mohsan Saeed at msaeed1@bu.edu

Some of our recent publications include:

• Chen DY, et al., Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation. 2023. Nature.
• Chin CV and Saeed M. Surgical strikes on host defenses: Role of the viral protease activity in innate immune antagonism. 2022, Pathogens.
• Weingarten-Gabbay S, et al., Profiling SARS-CoV-2 HLA-1 peptidome reveals T cell epitopes from out-of-frame ORFs. 2021. Cell.
• Chen DY, et al., SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway. 2021. Journal of Virology.
• Saeed M, et al., Defining the proteolytic landscape during enterovirus infection. 2020. PLoS Pathogens.

Please note all newly hired staff and faculty will need to be in compliance with Boston University’s COVID-19 Vaccination and Booster Requirement within 30 days of date of hire. You must upload your vaccine documentation or request a medical or religious exemption (instructions ). For further information on the University’s response to COVID-19, please visit the COVID-19 Resources site. 

We are an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, age, national origin, physical or mental disability, sexual orientation, gender identity, genetic information, military service, pregnancy or pregnancy-related condition, or because of marital, parental, or veteran status. We are a VEVRAA Federal Contractor.